[Application of cardiac assist device and its biomechanics research for heart failure]

Ying Chen1, Zhongjie Yin2, Wenchang Tan1

  • 1Shenzhen Graduate School, Peking University, Shenzhen, Guangdong 518055, P.R.China;College of Engineering, Peking University, Beijing 100871, P.R.China.

Insights

Cardiac assist devices are crucial for treating heart failure (HF). This review covers their current use, challenges, and future directions, offering insights for device improvement and clinical application.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Medical Devices

Background:

  • Heart failure (HF) is a significant clinical challenge requiring advanced treatment options.
  • Cardiac assist devices (CADs) represent a vital therapeutic modality for managing advanced HF.
  • The clinical application of CADs has expanded, necessitating a comprehensive review of their status.

Purpose of the Study:

  • To review the current application status, challenges, and future trends of cardiac assist devices.
  • To provide an overview of CAD classification, research achievements, and clinical indications.
  • To summarize recent advancements in heart biomechanics and hemodynamic studies related to CADs.

Main Methods:

  • Literature review of cardiac assist device applications and research.
  • Analysis of existing problems and future development trends in CAD technology.
  • Synthesis of biomechanical heart indexes and new HF treatment approaches.
  • Review of recent hemodynamic studies concerning cardiac assist devices.

Main Results:

  • Cardiac assist devices are established treatments for heart failure with evolving clinical indications.
  • Current challenges include device limitations, surgical complexity, and long-term outcomes.
  • Future trends focus on device miniaturization, improved biocompatibility, and advanced control systems.
  • Hemodynamic studies are crucial for understanding device-patient interactions and optimizing performance.

Conclusions:

  • Cardiac assist devices offer significant benefits for heart failure patients.
  • Addressing current limitations and embracing technological advancements will enhance CAD efficacy.
  • Further research into biomechanics and hemodynamics is essential for optimizing device design and clinical integration.
  • This review provides valuable references for improving cardiac assist device structure and clinical use.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
400
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
274
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
211
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
176
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
615